Literature DB >> 30883013

The burden of rare diseases.

Carlos R Ferreira1.   

Abstract

The subject of rare disease numbers is rife with misconceptions, not just in websites and other layman's literature, but also in the medical literature. Various websites mention numbers that are not validated by any solid data, while in turn the medical literature cites the aforementioned websites as sources, thus perpetuating a number of myths about rare diseases and their burden. We review the existing literature on rare disease numbers, in an attempt to demystify the subject. Specifically, we summarize data pertaining to: (a) known number and cumulative prevalence of rare diseases; (b) rare disease-associated mortality; (c) rare disease-associated morbidity, including numbers on health care services related to rare diseases; and (d) orphan drug numbers. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.

Keywords:  burden of disease; orphan drugs; prevalence; rare disease

Mesh:

Year:  2019        PMID: 30883013     DOI: 10.1002/ajmg.a.61124

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  59 in total

1.  Novel Therapies for Orphan Diseases.

Authors:  José M García Fernández; Carmen Ortiz Mellet
Journal:  ACS Med Chem Lett       Date:  2019-06-18       Impact factor: 4.345

2.  Children's rare disease cohorts: an integrative research and clinical genomics initiative.

Authors:  Shira Rockowitz; Nicholas LeCompte; Mary Carmack; Andrew Quitadamo; Lily Wang; Meredith Park; Devon Knight; Emma Sexton; Lacey Smith; Beth Sheidley; Michael Field; Ingrid A Holm; Catherine A Brownstein; Pankaj B Agrawal; Susan Kornetsky; Annapurna Poduri; Scott B Snapper; Alan H Beggs; Timothy W Yu; David A Williams; Piotr Sliz
Journal:  NPJ Genom Med       Date:  2020-07-06       Impact factor: 8.617

3.  Cou Cou, flying fish and a whole exome please... lessons learned from genetic testing in Barbados.

Authors:  Morris Hilary Scantlebury; Karlene Tanechia Barrett; Simeona Jacinto; David Orlando Christopher Corbin; Marina Kerr; Aneal Khan
Journal:  Pan Afr Med J       Date:  2021-02-03

Review 4.  [Rare diseases, digitization, and the National Action League for People with Rare Diseases (NAMSE)].

Authors:  Theda Wessel; Katharina Heuing; Miriam Schlangen; Birgit Schnieders; Markus Algermissen
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-10-14       Impact factor: 1.595

Review 5.  Understanding barriers to diagnosis in a rare, genetic disease: Delays and errors in diagnosing schwannomatosis.

Authors:  Vanessa L Merker; Bronwyn Slobogean; Justin T Jordan; Shannon Langmead; Mark Meterko; Martin P Charns; A Rani Elwy; Jaishri O Blakeley; Scott R Plotkin
Journal:  Am J Med Genet A       Date:  2022-06-09       Impact factor: 2.578

6.  Whole-genome sequencing of patients with rare diseases in a national health system.

Authors:  Ernest Turro; William J Astle; Karyn Megy; Stefan Gräf; Daniel Greene; Olga Shamardina; Hana Lango Allen; Alba Sanchis-Juan; Mattia Frontini; Chantal Thys; Jonathan Stephens; Rutendo Mapeta; Oliver S Burren; Kate Downes; Matthias Haimel; Salih Tuna; Sri V V Deevi; Timothy J Aitman; David L Bennett; Paul Calleja; Keren Carss; Mark J Caulfield; Patrick F Chinnery; Peter H Dixon; Daniel P Gale; Roger James; Ania Koziell; Michael A Laffan; Adam P Levine; Eamonn R Maher; Hugh S Markus; Joannella Morales; Nicholas W Morrell; Andrew D Mumford; Elizabeth Ormondroyd; Stuart Rankin; Augusto Rendon; Sylvia Richardson; Irene Roberts; Noemi B A Roy; Moin A Saleem; Kenneth G C Smith; Hannah Stark; Rhea Y Y Tan; Andreas C Themistocleous; Adrian J Thrasher; Hugh Watkins; Andrew R Webster; Martin R Wilkins; Catherine Williamson; James Whitworth; Sean Humphray; David R Bentley; Nathalie Kingston; Neil Walker; John R Bradley; Sofie Ashford; Christopher J Penkett; Kathleen Freson; Kathleen E Stirrups; F Lucy Raymond; Willem H Ouwehand
Journal:  Nature       Date:  2020-06-24       Impact factor: 49.962

7.  Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2020-03-06

8.  Novel PRMT7 mutation in a rare case of dysmorphism and intellectual disability.

Authors:  Jessie Poquérusse; Whitney Whitford; Juliet Taylor; Salam Alburaiky; Russell G Snell; Klaus Lehnert; Jessie C Jacobsen
Journal:  J Hum Genet       Date:  2021-07-09       Impact factor: 3.172

9.  First Chinese patient with mental retardation-40 due to a de novo CHAMP1 frameshift mutation: Case report and literature review.

Authors:  Yan Dong; Xiaoyi Shi; Kaixian Du; Ruijuan Xu; Tianming Jia; Jun Wang; Lijun Wang; Rui Han
Journal:  Exp Ther Med       Date:  2021-06-25       Impact factor: 2.447

Review 10.  Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases.

Authors:  Noa Hurvitz; Henny Azmanov; Asa Kesler; Yaron Ilan
Journal:  Eur J Hum Genet       Date:  2021-07-19       Impact factor: 5.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.